|View printer-friendly version|
Spring Bank Announces Collaborative Research Agreement with University of Texas Southwestern Medical School for Evaluation of STING Antagonist Compounds
“There is a significant unmet medical need for the treatment of diseases where the cGAS-STING pathway is dysregulated. We are excited to collaborate with
“We are excited to work with the scientists from UTSW as we advance our STING antagonist program,” said
In addition, the forward-looking statements included in this press release represent Spring Bank’s views as of the date hereof.
Source: Spring Bank Pharmaceuticals, Inc.